Peter Altman - 13 Feb 2024 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role: President and CEO, Director
Signature: /s/ David McClung, by power of attorney
Issuer symbol: BCDA
Transactions as of: 13 Feb 2024
Net transactions value: +$50,000
Form type: 4
Filing time: 15 Feb 2024, 07:00:19 UTC
Previous filing: 18 Aug 2023
Next filing: 28 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BCDA;BCDAW	Common Stock	Purchase	$50,000	+108,108	+24%	$0.4625	555,447	13 Feb 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BCDA;BCDAW	Warrant (right to buy	Purchase		+54,054	+80%		121,538	13 Feb 2024	Common Stock	54,054	$0.4423	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 13, 2024, the Registrant closed a private placement with certain qualified institutional buyers and institutional accredited investors, as well as the Reporting Person, wherein the Reporting Person received one share of common stock together with one warrant to purchase a share of common stock for each two shares of common stock purchased.